The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

Imagine wading through severe depression for years, taking medication after medication, with no relief. Now, envision discovering that what you were facing was not major depression but bipolar ...

Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial. The findings challenge ...

It is well-proven that cannabis use is associated with an increased risk of schizophrenia and heavy use of high-THC marijuana is associated with four times the normal rate of schizophrenia (see my ...

It wasn’t every day that Patricia Torres raced down the streets of Miami at 70 m.p.h. But then it wasn’t every day that her daughter Nicole Cabezas hallucinated wildly, trying to jump out of the car, ...

Kim Novak has been open about her struggles with bipolar disorder, which she said she first developed in the early 2000s.

The number of people in South Korea suffering from depression and bipolar disorder has increased by more than 40% over the past six years. In ...

A diagnostic distinction for postpartum psychosis in the DSM will improve detection, treatment, and prevention, an expert ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...